Emma A. Meagher

2.6k total citations · 1 hit paper
47 papers, 1.8k citations indexed

About

Emma A. Meagher is a scholar working on Surgery, Public Health, Environmental and Occupational Health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Emma A. Meagher has authored 47 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 13 papers in Public Health, Environmental and Occupational Health and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Emma A. Meagher's work include Lipoproteins and Cardiovascular Health (12 papers), Health and Medical Research Impacts (8 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Emma A. Meagher is often cited by papers focused on Lipoproteins and Cardiovascular Health (12 papers), Health and Medical Research Impacts (8 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Emma A. Meagher collaborates with scholars based in United States, Ireland and Italy. Emma A. Meagher's co-authors include Garret A. FitzGerald, Daniel J. Rader, Marina Cuchel, Joshua Rokach, Anne Burke, John A. Lawson, LeAnne T. Bloedon, Dirk Blom, Giovanni Battista Vigna and Maurizio Averna and has published in prestigious journals such as The Lancet, JAMA and Journal of Biological Chemistry.

In The Last Decade

Emma A. Meagher

44 papers receiving 1.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

2012 524 citations Marina Cuchel, Emma A. Meagher et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emma A. Meagher United States	16	683	393	322	305	278	47	1.8k
Garry X. Shen Canada	30	396 0.6×	394 1.0×	244 0.8×	265 0.9×	534 1.9×	99	2.3k
Zorana Jelić‐Ivanović Serbia	26	519 0.8×	493 1.3×	376 1.2×	137 0.4×	450 1.6×	103	2.3k
Marcelo Chiara Bertolami Brazil	25	685 1.0×	385 1.0×	345 1.1×	93 0.3×	224 0.8×	71	1.9k
Slavica Spasić Serbia	27	340 0.5×	352 0.9×	246 0.8×	231 0.8×	320 1.2×	82	1.7k
Neil S. Shachter United States	22	802 1.2×	859 2.2×	557 1.7×	216 0.7×	517 1.9×	32	2.3k
György Paragh Hungary	29	504 0.7×	401 1.0×	433 1.3×	94 0.3×	547 2.0×	136	2.7k
Alice Dowdy United States	13	1.1k 1.6×	977 2.5×	379 1.2×	222 0.7×	178 0.6×	17	2.1k
Anna Davoli Italy	28	359 0.5×	370 0.9×	370 1.1×	560 1.8×	670 2.4×	51	2.7k
Mariano Sentı́ Spain	27	615 0.9×	645 1.6×	617 1.9×	132 0.4×	692 2.5×	74	2.6k
Maria Cristina de Oliveira Izar Brazil	21	422 0.6×	273 0.7×	425 1.3×	81 0.3×	310 1.1×	113	1.7k

Countries citing papers authored by Emma A. Meagher

Since Specialization

Citations

This map shows the geographic impact of Emma A. Meagher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma A. Meagher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma A. Meagher more than expected).

Fields of papers citing papers by Emma A. Meagher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma A. Meagher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma A. Meagher. The network helps show where Emma A. Meagher may publish in the future.

Co-authorship network of co-authors of Emma A. Meagher

This figure shows the co-authorship network connecting the top 25 collaborators of Emma A. Meagher. A scholar is included among the top collaborators of Emma A. Meagher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma A. Meagher. Emma A. Meagher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rubio, Doris M., et al.. (2023). Customized Career Development Platform (CCDP) for clinical and translational researchers: A pragmatic cluster-randomized controlled trial. Journal of Clinical and Translational Science. 7(1). e259–e259.

Meagher, Emma A., Andrew D. Althouse, Cecília Maria Patino, et al.. (2022). Continued impact of COVID-19 pandemic on clinical and translational science early-career researchers. Journal of Clinical and Translational Science. 7(1). e7–e7. 1 indexed citations

Vogl, Dan T., et al.. (2021). A unique window of opportunity for practical reform of cancer clinical trials. Cancer. 127(16). 2855–2860. 1 indexed citations

Durbin, Dennis R., Stephanie House, Emma A. Meagher, & Jenna Griebel Rogers. (2019). The role of mentors in addressing issues of work–life integration in an academic research environment. SHILAP Revista de lepidopterología. 3(6). 302–307. 10 indexed citations

Raper, Anna, Daniel M. Kolansky, Bruce S. Sachais, et al.. (2014). Long-term clinical results of microsomal triglyceride transfer protein inhibitor use in a patient with homozygous familial hypercholesterolemia. Journal of clinical lipidology. 9(1). 107–112. 19 indexed citations

Cuchel, Marina, Dirk Blom, Maurizio Averna, et al.. (2013). Abstract 16516: Sustained LDL-C Lowering and Stable Hepatic Fat Levels in Patients With Homozygous Familial Hypercholesterolemia Treated With the Microsomal Triglyceride Transfer Protein Inhibitor, Lomitapide: Results of an Ongoing Long-Term Extension Study. Circulation. 11 indexed citations

Cuchel, Marina, Emma A. Meagher, Dirk Blom, et al.. (2012). Abstract 17396: Apheresis Treatment does not Affect the Lipid-Lowering Efficacy of Lomitapide, a Microsomal Triglyceride Transfer Protein Inhibitor, in Patients with Homozygous Familial Hypercholesterolemia. Circulation. 126. 3 indexed citations

Cuchel, Marina, Emma A. Meagher, Hendrik du Toit Theron, et al.. (2012). Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study. The Lancet. 381(9860). 40–46. 524 indexed citations breakdown →

Fisher, Naomi D.L. & Emma A. Meagher. (2011). Renin Inhibitors. Journal of Clinical Hypertension. 13(9). 662–666. 7 indexed citations

10.

Meagher, Emma A., et al.. (2011). Evaluating Research Mentors Working in the Area of Clinical Translational Science: A Review of the Literature. Clinical and Translational Science. 4(5). 353–358. 33 indexed citations

11.

Cuchel, Marina, Emma A. Meagher, A. David Marais, et al.. (2009). Abstract 1077: A Phase III Study of Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide (AEGR-733) in Patients With Homozygous Familial Hypercholesterolemia: Interim Results at 6 Months. Circulation. 120. 4 indexed citations

12.

Meagher, Emma A.. (2003). Balancing Gastroprotection and Cardioprotection with Selective Cyclo-Oxygenase-2 Inhibitors. Drug Safety. 26(13). 913–924. 17 indexed citations

13.

Merz, Jon F., Timothy R. Rebbeck, Pamela Sankar, & Emma A. Meagher. (2002). Pilot Study: Does the White Coat Influence Research Participation?. IRB Ethics and Human Research. 24(4). 6–6. 1 indexed citations

14.

Meagher, Emma A.. (2001). Effects of Vitamin E on Lipid Peroxidation in Healthy Persons. JAMA. 285(9). 1178–1178. 206 indexed citations

15.

Meagher, Emma A.. (2001). Antioxidant Therapy and Atherosclerosis Animal and Human Studies. Trends in Cardiovascular Medicine. 11(3-4). 162–165. 44 indexed citations

16.

Wolfe, Megan L., Joyce L. Ross, Emile R. Mohler, et al.. (2001). Safety and effectiveness of Niaspan when added sequentially to a statin for treatment of dyslipidemia. The American Journal of Cardiology. 87(4). 476–479. 79 indexed citations

17.

Meagher, Emma A. & Garret A. FitzGerald. (2000). Indices of lipid peroxidation in vivo: strengths and limitations. Free Radical Biology and Medicine. 28(12). 1745–1750. 245 indexed citations

18.

Reilly, Muredach P., Niamh Moran, Emma A. Meagher, et al.. (1999). A Randomized, Placebo-Controlled, Crossover Study of E5510 and Aspirin in Healthy Volunteers. Journal of Cardiovascular Pharmacology. 33(1). 12–18. 2 indexed citations

19.

Meagher, Emma A., Órla P. Barry, Anne Burke, et al.. (1999). Alcohol-induced generation of lipid peroxidation products in humans. Journal of Clinical Investigation. 104(6). 805–813. 199 indexed citations

20.

Fitzgerald, Garrett & Emma A. Meagher. (1994). Antiplatelet drugs. European Journal of Clinical Investigation. 24(S1). 46–49. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact